ÂÜÀòÂÒÂ×

Gerd Kochendoerfer has a range of work experience spanning several companies. Gerd started their most recent role as Chief Operating Officer at NFlection Therapeutics in September 2021. Prior to that, Gerd held the position of Senior Vice President and Head of Operations at PellePharm, a bridgebio company, from an unknown start date in 2017 until an unknown end date in 2023. Before PellePharm, they served as Senior Vice President of Technical Operations at Depomed from an unknown start date in 2008 until an unknown end date in 2017. Additionally, Gerd was a Senior Director of Drug Development at Fibrogen from an unknown start date in 2005 until an unknown end date in 2008. Lastly, they worked as the Director of Research and Development at Gryphon Therapeutics from an unknown start date in 1997 until an unknown end date in 2005.

Gerd Kochendoerfer received their Ph.D. in Chemistry from the University of California, Berkeley, where they studied from 1992 to 1997. Prior to that, they attended Heidelberg University from 1987 to 1992.